Extracorporeal Membrane Oxygenation in Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute

Jérome Rambaud1, Ryan P Barbaro2, Duncan J Macrae3

  • 1Departement of Pediatric and Neonatal Intensive Care, Armand-Trousseau Hospital, Sorbonne University, Paris, France.

Insights

This review provides updated clinical practice and research recommendations for extracorporeal membrane oxygenation (ECMO) in pediatric acute respiratory distress syndrome (PARDS). It synthesizes evidence to guide ECMO use in critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Medicine
  • Extracorporeal Life Support

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) is a severe condition requiring advanced respiratory support.
  • Extracorporeal membrane oxygenation (ECMO) is a vital therapy for severe PARDS, but clinical practice guidelines require regular updates.
  • The Pediatric Acute Lung Injury Consensus Conference (PALICC) aims to refine recommendations for ECMO in PARDS.

Approach:

  • A systematic literature review was conducted using MEDLINE, Embase, and CINAHL Complete databases.
  • Studies focused on ECMO for PARDS or acute respiratory failure, excluding animal models and case reports.
  • The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach informed evidence synthesis and recommendation development.

Key Points:

  • Eighteen studies were included in the full-text review, with consideration of adult and neonatal data when pediatric data was limited.
  • Six clinical recommendations were generated covering ECMO indications, initiation, and management in PARDS.
  • Three good practice statements, two policy statements (on team organization and training), and one research statement were developed.

Conclusions:

  • The review proposes updated clinical management, good practice, and policy statements for ECMO in PARDS.
  • These statements address critical aspects including indications, initiation, team organization, training, management, and follow-up.
  • The findings aim to enhance the quality of care and guide future research in pediatric ECMO for respiratory failure.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
189
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
50
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
180
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
277
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
258